Unlocking the Power of Spatial Proteomics: Innovations and Real-World Applications
Presented by Charlotte Stadler and Adyary Fallarero
Join us for an insightful webinar showcasing the Invitrogen™ EVOS™ S1000 Spatial Imaging System and its significant impact on spatial proteomics. Discover how this advanced technology simplifies multiplex imaging, enabling valuable insights into tissue environments. We will explore real-world applications, including compelling examples from SciLifeLab Spatial Proteomics Infrastructure Unit presented by Associate Prof. Charlotte Stadler. Learn how the EVOS S1000 is being utilized to advance research in disease mechanisms and pathology.
Key Learning Points
- Introduction to Spatial Biology: Understand the fundamentals of spatial proteomics and its significance in modern research.
- Learn the benefits and drawbacks of technology options available for multiplex fluorescence imaging.
- Innovations in Imaging tools: Discover how spatial proteomics can be advanced using spectral multiplex fluorescence.
- Explore how the EVOS S1000 Imaging System streamlines the process of tissue imaging for spatial localization of proteins.
- Case Study from SciLifeLab: Learn about the services offered by the spatial proteomics core facility at SciLifeLab
- Hear from Dr. Charlotte Stadler on how the EVOS S1000 is utilized at SciLifeLab.
- Understand the specific examples of its applications in studying disease mechanisms and pathology.
Benefits for Attendees
- Enhanced Knowledge: Attendees will gain a deeper understanding of spatial proteomics and the latest advancements in imaging technology.
- Practical Insights: Learn how to apply these technologies in your own research to uncover new insights into cellular environments.
- By attending this webinar, participants will be equipped with the knowledge and imaging tools to leverage the power of spatial proteomics in their research, driving innovation and discovery.
Speaker Bio
Charlotte Stadler, Associate Professor
Charlotte Stadler is the co-director of the Spatial Biology platform and Head of the National Spatial Proteomics facility at Science for Life Laboratory. She is also a Principal Investigator at the Royal Institute of Technology. She received her Ph.D. in 2012 within the framework of the Human Protein Atlas (HPA) project, with Prof. Emma Lundberg and Prof. Mathias Uhlén as her supervisors. During her PhD she established many of the protocols and pipelines for image based subcellular protein profiling that are used in the Human Protein Cell Atlas.
Today, her main focus is to develop and implement services and technologies within spatial biology that can be used projects ranging from discovery to translational and clinical research. In her role she works with many companies in the spatial omics field including Thermo Fisher Scientific. Her internal research projects focus on the implementation and adaptation of multiplexed imaging solutions into clinical practice but also on integrating different omics types for a more complete molecular understanding of the tissue sample biology.
Adyary Fallarero, Senior Manager, Product Management.
Adyary Fallarero is a Sr. Manager within Product Management at Thermo Fisher. She is an Adjunct Professor in Pharmaceutical Biology at the Faculty of Pharmacy, University of Helsinki, Finland. She earned PhD in Biochemistry from the University of Havana, Cuba and a Master in International Business Management (MBA) from the Tampere University of Applied Sciences, in Finland.
During her more than 10 years of academic career, she published over 75 peer-reviewed publications, co-authored over 10 patents, and was awarded multiple grants to lead research programs focused on early drug discovery of anti-biofilms. In 2018, she received the prestigious Oskar Öflund’s Foundation Grand Prize, for her contributions to the development of the field of bacterial biofilms in Finland.
She joined Thermo Fisher Scientific in 2016 to work on cell analysis instrumentation, gaining significant expertise in new product development and product management. Since 2021, she has been responsible for new product introductions, portfolio management and commercial enablement covering Imaging Systems.